SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 213 filers reported holding SAGE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,422 | +129.2% | 555 | +423.6% | 0.00% | – |
Q2 2023 | $4,984 | +18.8% | 106 | +6.0% | 0.00% | – |
Q1 2023 | $4,196 | +10.0% | 100 | 0.0% | 0.00% | – |
Q4 2022 | $3,814 | -4.6% | 100 | -6.5% | 0.00% | – |
Q3 2022 | $4,000 | -20.0% | 107 | -27.7% | 0.00% | – |
Q2 2022 | $5,000 | -28.6% | 148 | -15.9% | 0.00% | – |
Q4 2021 | $7,000 | -22.2% | 176 | -17.8% | 0.00% | – |
Q3 2021 | $9,000 | +50.0% | 214 | +94.5% | 0.00% | – |
Q2 2021 | $6,000 | -25.0% | 110 | 0.0% | 0.00% | – |
Q1 2021 | $8,000 | -20.0% | 110 | 0.0% | 0.00% | -100.0% |
Q4 2020 | $10,000 | +42.9% | 110 | 0.0% | 0.00% | – |
Q3 2020 | $7,000 | – | 110 | +450.0% | 0.00% | – |
Q2 2020 | $0 | -100.0% | 20 | -88.3% | 0.00% | – |
Q1 2020 | $4,000 | 0.0% | 171 | +533.3% | 0.00% | – |
Q3 2019 | $4,000 | -20.0% | 27 | 0.0% | 0.00% | – |
Q2 2019 | $5,000 | +25.0% | 27 | 0.0% | 0.00% | – |
Q1 2019 | $4,000 | +300.0% | 27 | +200.0% | 0.00% | – |
Q3 2018 | $1,000 | -50.0% | 9 | -47.1% | 0.00% | – |
Q2 2018 | $2,000 | -33.3% | 17 | -19.0% | 0.00% | – |
Q1 2018 | $3,000 | – | 21 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 5,149,482 | $105,976,340 | 2.24% |
Palo Alto Investors LP | 1,005,776 | $20,698,870 | 1.96% |
Boxer Capital, LLC | 1,094,000 | $22,514,520 | 1.20% |
Bellevue Group AG | 3,513,351 | $72,304,764 | 1.16% |
PDT Partners, LLC | 181,625 | $3,737,843 | 0.47% |
EASTERLY INVESTMENT PARTNERS LLC | 195,643 | $4,026,333 | 0.44% |
Harvest Investment Services, LLC | 30,302 | $623,615 | 0.40% |
Simplify Asset Management Inc. | 120,030 | $2,470,217 | 0.28% |
SAMLYN CAPITAL, LLC | 739,867 | $15,226,463 | 0.25% |
CAXTON ASSOCIATES LP | 68,035 | $1,400,160 | 0.19% |